Results 131 to 140 of about 1,925 (192)

Bivalent RSV prefusion F vaccination elicits effective neutralization of contemporary and monoclonal antibody-resistant RSV strains. [PDF]

NPJ Vaccines
Chen W, Martinez LT, Falcao L, Li Z, McKeen AP, Kurhade C, Boigard H, Roopchand V, Richardson I, Dasgupta T, Llamera KE, Colatat J, Brock LG, Anderson AS, Swanson KA.   +14 more
europepmc   +1 more source

Nirsevimab in High-Risk Infants in a Respiratory Syncytial Virus Prevention Strategy.

JAMA Netw Open
Sauré D, Torres JP, Goic M, Thraves C, Pacheco J, Burgos J, Zgheib A, Del Solar F, Neira I, O'Ryan M, Basso LJ.   +10 more
europepmc   +1 more source

Infant Respiratory Syncytial Virus Immunization Through Maternal Vaccination and Nirsevimab. [PDF]

JAMA Netw Open
Acker KP, Strobino K, DeAngelis JM, Staniczenko AP, Son M, Riley LE, Han JY, Abramson EL, Grinspan ZM, Levine DA.   +9 more
europepmc   +1 more source

Determinants of success and failure of antibody-based strategies against respiratory viruses: insights from RSV and SARS-CoV-2. [PDF]

Front Immunol
Guo H, Wang H, Wu S, Lin H, Wang G, Pu Q.   +5 more
europepmc   +1 more source

In response to the article «Reluctance of parents to immunize their children with nirsevimab»

Anales de Pediatría (English Edition)
David, Andina Martínez, Esther, Fernández Mozo, Rocio, Trincado Lamuño, Jose Antonio, Alonso-Cadenas   +3 more
openaire   +2 more sources

Impact of nirsevimab universal prophylaxis on RSV bronchiolitis hospitalizations. A tertiary level children's hospital perspective. [PDF]

Front Pediatr
Tonetto S, Cason C, Fasiolo E, Dal Cin M, Cozzi G, Giangreco M, Zappetti C, Nider S, Amaddeo A, Comar M, Travan L.   +10 more
europepmc   +1 more source

Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysis. [PDF]

Lancet Reg Health Eur
Perramon-Malavez A, Chiaretti A, Coma E, Craiu M, Foster S, Leonard P, Marlow R, Thors V, Martínez-Marcos M, Mendioroz J, Vila J, Creus-Costa A, Prats C, Roland D, Soriano-Arandes A, Williams TC, Buonsenso D.   +16 more
europepmc   +1 more source

The S190R mutation in RSV-A F protein impairs nirsevimab binding and neutralization capacity. [PDF]

Virus Evol
Cordela S, Harari J, Moirangthem R, Khaleafi R, Kladnitsky O, Duran D, Grunewald M, Bar-On Y.   +7 more
europepmc   +1 more source

RSV Prevention Products and Severe RSV-Associated Disease Among Infants.

JAMA Netw Open
Bennett JC, Bevers E, Chronister S, McHugh A, Choudry M, Huynh M, Englund JA, Lindquist S, Holshue ML.   +8 more
europepmc   +1 more source